Evaluation of safety and efficacy of supirocin-B (mupirocin 2% + betamethasone dipropionate 0.05%) in infected dermatoses--a post marketing study.

Savant, S; Janaki, V R; Mittal, R R; Sengupta, S; Desai, A

Savant, S; Janaki, V R; Mittal, R R; Sengupta, S; Desai, A.

J Indian Med Assoc ; 2000 Apr; 98(4): 194-5

Article in En | IMSEAR | ID: sea-102706

Subject(s)

Betamethasone/administration & dosage; Drug Combinations; Humans; India; Mupirocin/administration & dosage; Ointments; Product Surveillance, Postmarketing; Pyoderma/drug therapy; Staphylococcal Skin Infections/drug therapy; Streptococcal Infections/drug therapy; Treatment Outcome

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Ointments / Product Surveillance, Postmarketing / Pyoderma / Streptococcal Infections / Staphylococcal Skin Infections / Humans / Betamethasone / Treatment Outcome / Mupirocin / Drug Combinations Type of study: Evaluation_studies Country/Region as subject: Asia Language: En Journal: J Indian Med Assoc Year: 2000 Type: Article

Fulltext

Add to My VHL

XML

Search on Google